ARCHIVES
VOL. 3, ISSUE 2 (2021)
Remdesivir: A promising drug against COVID-19
Authors
Kity Maurya, Aneeta Sen
Abstract
Whole world is suffering from severe health hazards, which is in the form of Severe Acute Respiratory Syndrome. Remdesivir (G-5374) is considered to be one of the most promising drug against COVID-19 as it as antiviral properties which are helpful in decreasing the length of illness period and need of ventilators for the patients. It is a nucleoside analog which has broad spectrum antiviral activities. It has been tested for many viral diseases like EBOLA, MERS, SARS and SARS Co-V-2. It has been seen that remdesivir decreases the death rates in some of the countries. It has been approved by US and Japan for using it intravenously for treating hospitalized patients. India is also using remdesivir to overcome the present scenario as the Indian variant of COVID -19 has affected middle aged people in the second wave in India. It’s a drug which was manufactured by Gilead Sciences, a pharmaceutical company which works mainly to develop antiviral drugs. It was firstly used for EBOLA virus during it’s outbreak in South Africa. With the start of pandemic, the use of remdesivir started for patients of COVID -19 infections. It has been seen that it is effective when it is administered in early stages of the infection. Remdesivir interfere with the RNA replication of the virus and thus inhibit it’s activity. Many clinical trials have shown that remdesivir has decreased the supplementary oxygen requirement. Many trails have also warned about the side effects of this drug. But as the infection of COVID-19 has engulfed many people. Many countries has lost most of the population and struggling with it, it has been suggested that an oral antiviral drug must be develop which must have high potential, high antiviral activity so that the present scenario of pandemic could be finished and the transmission of COVID -19 could be stopped. Still, there is need of more potential clinical trials seeking for the effectiveness of remdesivir along with other drugs. It has been suggested that more studies must be done to understand the clear side effects of the drug.
Download
Pages:28-31
How to cite this article:
Kity Maurya, Aneeta Sen "Remdesivir: A promising drug against COVID-19 ". International Journal of Educational Research and Development, Vol 3, Issue 2, 2021, Pages 28-31
Download Author Certificate
Please enter the email address corresponding to this article submission to download your certificate.